Fmr LLC Xenon Pharmaceuticals Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Fmr LLC holds 8,884,363 shares of XENE stock, worth $355 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

8,884,363

Previous 8,287,499 7.2%

Holding current value

$355 Million

Previous $278 Million 0.01%

% of portfolio

0.02%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$28.23 - $38.37 $16.8 Million - $22.9 Million	596,864 Added 7.2%	8,884,363 $278 Million
Q1 2025 May 12, 2025	BUY	$33.55 - $40.74 $25.6 Million - $31.1 Million	762,209 Added 10.13%	8,287,499 $278 Million
Q4 2024 Feb 13, 2025	BUY	$38.14 - $45.74 $23.2 Million - $27.8 Million	607,606 Added 8.78%	7,525,290 $295 Million
Q3 2024 Nov 13, 2024	BUY	$36.12 - $43.96 $5.4 Million - $6.57 Million	149,511 Added 2.21%	6,917,684 $272 Million
Q2 2024 Aug 13, 2024	BUY	$36.25 - $43.75 $6.03 Million - $7.28 Million	166,343 Added 2.52%	6,768,173 $264 Million
Q1 2024 May 13, 2024	BUY	$42.66 - $50.04 $40.4 Million - $47.3 Million	945,908 Added 16.72%	6,601,830 $284 Million
Q4 2023 Feb 13, 2024	BUY	$28.7 - $46.46 $40.3 Million - $65.2 Million	1,403,056 Added 32.99%	5,655,922 $261 Million
Q3 2023 Nov 13, 2023	SELL	$34.16 - $39.73 $32 Million - $37.2 Million	-935,841 Reduced 18.04%	4,252,866 $145 Million
Q2 2023 Aug 11, 2023	BUY	$34.84 - $43.54 $16.1 Million - $20.1 Million	460,858 Added 9.75%	5,188,707 $200 Million
Q1 2023 May 11, 2023	BUY	$33.46 - $40.35 $1.24 Million - $1.49 Million	37,020 Added 0.79%	4,727,849 $169 Million
Q4 2022 Feb 13, 2023	BUY	$33.06 - $39.43 $696,574 - $830,790	21,070 Added 0.45%	4,690,829 $185 Million
Q3 2022 Nov 10, 2022	BUY	$30.79 - $39.82 $3 Million - $3.88 Million	97,391 Added 2.13%	4,669,759 $169 Million
Q2 2022 Aug 12, 2022	BUY	$25.44 - $35.16 $18.8 Million - $26 Million	738,892 Added 19.27%	4,572,368 $139 Million
Q1 2022 May 13, 2022	SELL	$25.09 - $33.13 $1.92 Million - $2.54 Million	-76,541 Reduced 1.96%	3,833,476 $117 Million
Q4 2021 Feb 14, 2022	BUY	$15.6 - $35.4 $13.3 Million - $30.2 Million	853,261 Added 27.91%	3,910,017 $122 Million
Q3 2021 Nov 15, 2021	SELL	$14.86 - $19.45 $233,123 - $305,131	-15,688 Reduced 0.51%	3,056,756 $46.7 Million
Q2 2021 Aug 13, 2021	BUY	$16.81 - $20.0 $51.6 Million - $61.4 Million	3,072,444 New	3,072,444 $57.2 Million

Others Institutions Holding XENE

# of Institutions

221

Shares Held

72.7M

Call Options Held

336K

Put Options Held

309K

View Full List

About Xenon Pharmaceuticals Inc.

Ticker XENE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,263,500
Market Cap $2.49B
Description
Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...

More about XENE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account